Oxford spinout spies the hidden mechanics of DNA and disease

Nucleome Therapeutics has found a new way to depict and analyze DNA with super-fine resolution, allowing them to peer into “the dark matter of the human genome” and the molecular basis of many diseases. What they hope to find are answers about COVID-19 severity—and new drug targets for multiple sclerosis and rheumatoid arthritis.

Related Keywords

James Davies , Danuta Jeziorska , University Of Oxford , Weatherall Institute Of Molecular Medicine , Molecular Medicine , Coronavirus , Nucleome Therapeutics , Covid 19 , Na Sequencing , Diagnostic Tests , Multiple Sclerosis , Rheumatoid Arthritis , Medtech , ஜேம்ஸ் டேவிஸ் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , மூலக்கூறு மருந்து , மெதிதேச் ,